Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 31.08.2026 7 AIDS 1 AIDS Res Hum Retroviruses 1 Clin Infect Dis 3 HIV Med 1 Int J Cancer 4 J Acquir Immune Defic Syndr 5 J Infect Dis 1 J Virol 1 Lancet Infect Dis 1 Nat Med 1 Pediatr Infect Dis J 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. LAMAIZON CS, Cecchini D, Brizuela M, Copertari G, et al
   Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.
   AIDS. 2026;40:1587-1590.
   PubMed         Abstract available
   
   
2. RODRIGUES K, Bahrambegi R, Reid M
   Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.
   AIDS. 2026;40:1585-1587.
   PubMed         Abstract available
   
   
3. VARADARAJAN M, Byrne R, Al-Hussaini A, Halliday B, et al
   The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.
   AIDS. 2026;40:1582-1585.
   PubMed         Abstract available
   
   
4. BUZON L, Bernal-Morell E, Montes ML, Gisbert L, et al
   Rethinking HIV resistance in the era of long-acting therapy: from isolated events to durable exposure.
   AIDS. 2026;40:1577-1581.
   PubMed        
   
   
5. MUJUGIRA A, Nsubuga R, Nakyanzi A, Bagaya M, et al
   Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.
   AIDS. 2026;40:1508-1516.
   PubMed         Abstract available
   
   
6. SHUAIB M, Odayar J, Phillips TK, Malaba TR, et al
   Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.
   AIDS. 2026 Aug 25. doi: 10.1097/QAD.0000000000004603.
   PubMed         Abstract available
   
   
7. PANNEER N, France AM, Billock RM, Islam MH, et al
   Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.
   AIDS. 2026 Aug 25. doi: 10.1097/QAD.0000000000004609.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

8. TAGLIAFERRI RAEL C, Das D, Giguere R, Porter J, et al
   Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa.
   AIDS Res Hum Retroviruses. 2026 Aug 24:8892229261480775.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

9. DIARRA A, Vignier N, Tantet C, Petit B, et al
   When Choosing Antiretroviral Therapy Meets Immigration Policy: An Ethical Analysis.
   Clin Infect Dis. 2026 Aug 25:ciag442. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   HIV Med

10. KITT H, Kelly C, Aghaizu A, Ross M, et al
    Wellbeing of trans and gender-diverse people with HIV in the United Kingdom: Results from Positive Voices 2022.
    HIV Med. 2026 Aug 27. doi: 10.1111/hiv.70286.
    PubMed         Abstract available
    
    
11. SONKAYA A, Ceran N, Senbayrak S, Inan A, et al
    Medication burden and prescribing quality in older people living with HIV: Associations with quality of life.
    HIV Med. 2026 Aug 26. doi: 10.1111/hiv.70301.
    PubMed         Abstract available
    
    
12. BARBER TJ, Boffito M, Gilleece Y, Jackson P, et al
    CROI 2026-A summary from the BHIVA CROI Working Group.
    HIV Med. 2026 Aug 25. doi: 10.1111/hiv.70302.
    PubMed        
    
    

    
    Int J Cancer

13. ROZEMEIJER K, Claesen J, Dias Goncalves Lima F, Hesselink AT, et al
    Toward Objective Anal Cancer Screening: From Swab-Based Genome-Wide Methylation Marker Discovery to Novel Test Development.
    Int J Cancer. 2026 Aug 27. doi: 10.1002/ijc.70708.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

14. BRAULT MA, Ahonkhai AA, Frndak S, Colt S, et al
    Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort Study.
    J Acquir Immune Defic Syndr. 2026 Aug 24. doi: 10.1097/QAI.0000000000003959.
    PubMed         Abstract available
    
    
15. FUSCO P, Russo A
    Once-weekly oral islatravir plus lenacapavir: clinical considerations for individualized use.
    J Acquir Immune Defic Syndr. 2026 Aug 24. doi: 10.1097/QAI.0000000000003960.
    PubMed         Abstract available
    
    
16. ZOU S, Yan Y, Ye J, Liu J, et al
    Cellular immune response of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2026 Aug 27. doi: 10.1097/QAI.0000000000003961.
    PubMed         Abstract available
    
    
17. CHANDRA C, Maloney KM, Le Guillou A, Hoover KW, et al
    Modeling the Potential Impact of Scaling Up Event-Driven PrEP Among Gay, Bisexual, and Other Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2026 Aug 28. doi: 10.1097/QAI.0000000000003934.
    PubMed         Abstract available
    
    

    
    J Infect Dis

18. RANGARAJ A, Ford N
    Simplifying CD4 testing to support advanced HIV disease care.
    J Infect Dis. 2026 Aug 22:jiag438. doi: 10.1093.
    PubMed        
    
    
19. FARCET MR, Karbiener M, Kreil TR
    Serosurvey for Antibodies to Bourbon Virus and Related Thogotoviruses in Immunoglobulin Lots Obtained From Human Plasma Collected in the United States and Europe.
    J Infect Dis. 2026 Aug 24:jiag442. doi: 10.1093.
    PubMed         Abstract available
    
    
20. ADZEMOVIC T, Nalintya E, Onencan P, Enock O, et al
    Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.
    J Infect Dis. 2026 Aug 24:jiag437. doi: 10.1093.
    PubMed         Abstract available
    
    
21. KHAYARGOLI P, Grace D, Cox J, de Pokomandy A, et al
    HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.
    J Infect Dis. 2026 Aug 26:jiag426. doi: 10.1093.
    PubMed         Abstract available
    
    
22. WATTIAU P, Omar SV, Joseph L, Demoitie MA, et al
    Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.
    J Infect Dis. 2026 Aug 28:jiag428. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

23. KIM SJ, Janssens J, Isbell C, Wedrychowski A, et al
    HIV DNA and transcription before and after ART in natural controllers compared to noncontrollers.
    J Virol. 2026 Aug 24:e0048226. doi: 10.1128/jvi.00482.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

24. MBOIZI R, Sekikubo M, Businge GB, Mukasa Z, et al
    Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.
    Lancet Infect Dis. 2026 Aug 25:S1473-3099(26)00318.
    PubMed         Abstract available
    
    

    
    Nat Med

25. MUHINDO MUYISA R, Kavugho Loando V, Kavira Kavulivwa L, Katsuva Ngowire D, et al
    Beyond Ebola: armed conflict and humanitarian funding cuts threaten control of malaria, TB and HIV in eastern DRC.
    Nat Med. 2026 Aug 25. doi: 10.1038/s41591-026-04592.
    PubMed        
    
    

    
    Pediatr Infect Dis J

26. MUSSI-PINHATA MM, Yamamoto AY, Hofer CB, Watts J, et al
    Cytomegalovirus Shedding in Brazilian Pregnant Women Living With HIV on Combination Antiretrovirals and CMV Infection in Infants.
    Pediatr Infect Dis J. 2026 Aug 26. doi: 10.1097/INF.0000000000005384.
    PubMed         Abstract available
    
    

    
    PLoS One

27. PHIRI TN, Dumbura C, Mutasa K, Ngosa D, et al
    A cross?sectional analysis of vitamin D status and associated factors in children recovering from severe acute malnutrition in Zambia and Zimbabwe.
    PLoS One. 2026;21:e0355404.
    PubMed         Abstract available
    
    
28. VIVAS-VALENCIA C, Webb KA, Flanagan CF, Takarinda K, et al
    Optimizing the location of point-of-care infant HIV testing devices in Zimbabwe to maximize impact and value: A modeling analysis.
    PLoS One. 2026;21:e0350921.
    PubMed         Abstract available
    
    
29. JOHNSON AK, Devlin SA, Barkowski CMA, Goldstein A, et al
    Enhancing uptake of PrEP for her via organizational research and individual actions (EUPHORIA): Protocol for a stepped-wedge cluster randomized trial.
    PLoS One. 2026;21:e0355623.
    PubMed         Abstract available
    
    
30. STANSFIELD SE, Moore M, Boily MC, Hughes JP, et al
    Estimated benefits of providing on-demand pre-exposure prophylaxis options for cisgender women in South Africa: A modeling study.
    PLoS One. 2026;21:e0357094.
    PubMed         Abstract available
    
    
31. FERNANDEZ-SANCHEZ H, Jones J, Arandhara U, Padhye N, et al
    Prevalence and characteristics of sex trafficking among youth experiencing homelessness: A cross-sectional study.
    PLoS One. 2026;21:e0357091.
    PubMed         Abstract available
    
    
32. LOLEKHA R, Suntarattiwong P, Boon-Yasidhi V, Na-Nakorn Y, et al
    Career and education outcomes among people who acquired HIV perinatally and received care at two tertiary care hospitals in Bangkok, 2014-2020.
    PLoS One. 2026;21:e0348339.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum